Skip to main content
. 2017 Mar 31;8(32):52571–52583. doi: 10.18632/oncotarget.16732

Figure 4. Survival analysis of PDAC patients by Kaplan-Meier plots and log-rank tests.

Figure 4

Patients were categorized by high and low expression of ERO1A, OSBPL3 and IFI44L respectively based on IHC staining scores. *p<0.05, **p<0.01.